SMAD公司
增生性瘢痕
污渍
逆转录聚合酶链式反应
分子生物学
化学
免疫细胞化学
转化生长因子
基因表达
细胞质
免疫组织化学
细胞生物学
生物
内科学
医学
内分泌学
病理
基因
生物化学
作者
Shaohai Qi,Ju Lin Xie,Shu Pan,Ying Xu,T.-Z. Li,Jun Tang,X.-S. Liu,Bin Shu,Peng Liu
标识
DOI:10.1111/j.1365-2230.2007.02636.x
摘要
BACKGROUND: The precise mechanism of asiaticoside in molecular and gene expression levels of Smad protein and mRNA still remains unknown. We hypothesised that asiaticoside might inhibit the formation of hypertrophic scarring by affecting the expression of Smad protein and interfering with the Smad signalling pathway. AIMS: To investigate the effects of asiaticoside on the expression of Smad protein by hypertrophic scar fibroblasts (HSFs) and to clarify the mechanism of asiaticoside in scar treatment. METHODS: Normal skin fibroblasts and HSFs were exposed to various concentrations of asiaticoside in serum-free medium for 72 h, then immunocytochemistry was used to examine the localization and expression of phosphorylated Smad2 and Smad7. The expression of Smad protein was studied both at the transcriptional and post-transcriptional levels, using conventional reverse transcription PCR and Western blotting. RESULTS: Asiaticoside markedly enhanced the expression of inhibitory Smad7, but it had no effect on the expression of Smad2. Further study revealed that asiaticoside could induce Smad7 to enter the cytoplasm from the nucleus. CONCLUSIONS: Asiaticoside inhibits scarring probably by enhancing the expression of inhibitory Smad7, and is a potential treatment for scarring.
科研通智能强力驱动
Strongly Powered by AbleSci AI